The fiscally reckless Medicare Part D drug benefit –passed by a Republican Congress and signed by a Republican President– continues to add to the US federal deficit and debt. I’m resigned to this program’s continuation but perhaps there is hope for it to be modified or somehow...
Posted to
News
on Thu, Jun 13 2013
Filed under: Research, Policy and politics, Pharma
Shire, a mid-sized pharmaceutical company based in Ireland, has a new CEO, Flemming Ornskov. One of his first actions after taking over was to move to the Boston area, where Shire’s rare disease division is located. He told the Boston Globe: “When I got the job, I said to the board that as Shire...
Posted to
News
on Wed, Jun 12 2013
Filed under: Pharma
I’m excited to be presenting in the Fall with Adam Fein and lots of other great speakers at the 2nd Bio/Pharma Retail Strategy Summit to be held September 18-19 in Philadelphia, PA. I get to talk about one of my favorite topics which is how health reform is driving change in the industry and […...
Posted to
News
on Wed, Jun 12 2013
Filed under: Healthcare, Pharma, Health reform, Conference, PPACA, Consumerism, mHealth, presentation, QuantifiedSelf, discount code, CBI
When we ask ‘is pharma afraid of social media?‘, we may not be posing the question we think we are. For once, we’ll disregard the usual preliminary objections concerning the identity of the companies we assume we are referring to, and the unhelpfully homogeneous bulk descriptor which...
Posted to
News
on Tue, Jun 4 2013
Filed under: Social Media, Analysis, Pharma, social business